3
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Nitric oxide generation by peripheral blood cells in chronic renal failure

, , , , &
Pages 24-29 | Accepted 24 Sep 2001, Published online: 27 Oct 2016

References

  • Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109–42.
  • Moncada S, Higgs H. The L-arginine–nitric oxide pathway. N Engl J Med 1993; 329: 2002–12.
  • Radomski MW, Palmer RMJ, Moncada S. An L-arginine:nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 1990; 87: 5193- 7.
  • Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium derived vascular relaxing factor. Nature 1986; 320: 454–6.
  • Bechman JS, Beckman TV, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620–4.
  • Remuzzi G. Bleeding in renal failure. Lancet 1988; i: 1205–8.
  • Van Holder R, Ringoir S, Dhondt A, Hakim R. Phagocytosis in uremia and hemodialysis: a prospective and cross-sectional study. Kidney Int 1991; 39: 320–7.
  • Colton CK, Ward Ra, Shaldon S. Scientific basis for assessment of biocompatibility in extracorporeal blood treatment. Nephrol Dial Transplant 1994; 9 (Suppl 2): 11–7.
  • Rysz J, Luciak M, Kendziora J, Blaszczyk J, Sibinska E. Nitric oxide release in the peripheral blood during hemodialysis. Kidney Int 1997; 51: 294–300.
  • Vallance P, Leone A, Calver A, Collier J, Moncada s. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572–5.
  • Vaziri ND, Ni Z, Wang XQ, Oveisi F, Zhois XS. Down-regulation of nitric oxide synthase in chronic renal insufficiency: role of excess PTH. Am J Physiol 1998; 274: F642-F649.
  • Noris M, Benigni A, Boccardo P et al. Enhanced nitric oxide synthesis in uremia: implication for platelets dysfunction and dialysis hypotension. Kidney Int 1997; 44: 445–50.
  • Aiello S, Noris M, Todeschini M et al. Renal and systemic nitric oxide synthesis in rat with renal mass reduction. Kidney Int 1997; 50: 171–81.
  • Haslett C, Guthrie LA, Ropaniak MM, Johnston RB, Henson PM. Modulation of multiple neutrophil functions by preparative method or trace concentrations of bacterial lipopolysaccharide. Am J Pathol 1985; 119: 101–10.
  • Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84: 9265–9.
  • Marklund S, Marklund G. Involvement of Superoxide anion radical in autoxidation of pyrogallol and a convenient assay for SOD. Eur J Biochem 1974; 47: 469–74.
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurements with Folin-phenol reagent. J Biol Chem 1951; 193: 265–70.
  • Dacie SJV, Lewis SM. Basic haematological techniques. In: Practical haematology 7th ed. London: Churchill Livingstone, 1991: 37–61.
  • Chase N, Bown F. The linear correlation coefficient In: General statistics, 2nd ed. John Willey and Sons, 1992: 479.
  • Joly GA, Schini VB, Vanhoutte PM. Balloon injury and interleukin-1b-induced nitric oxide synthase activity in rat carotid arteries. Circ Res 1992; 71: 331–8.
  • Stamler JS, Loscalzo J. The antiplatelet effects of organic nitrates and related nitrosocompounds in vitro and in vivo and their relevance to cardiovascular disorders. J Am Coll Cardiol 1991; 18: 1529–36.
  • Raine AE, Bedford L, Simpson AW et al. Hyperparathyrodism platelet intracellular free calcium and hypertension in chronic renal failure. Proc Natl Acad Sci USA 1993; 43: 700–5.
  • Moosa A, Greaves M, Brown CB, McNeil S. Elevated platelet free calcium in uraemia. Br J Haematol 1990; 74: 300–5.
  • Arese M, Strasly M, Ruva C et al. Regulation of nitric oxide synthesis in uremia (Abstract). Nephrol Dial Transplant 1997; 10: 1386–97.
  • Porter CJ, Burden RP, Morgan AG, Daniels I, Fletcher J. Impaired polymorphonuclear neutrophil function in end-stage renal failure and its correction by continuous ambulatory dialysis. Nephron 1995; 71: 133–7.
  • Clancy RM, Leszcznska–Piziak J, Abramson SB. Nitric oxide an endothelial cell relaxing factor inhibits neutrophilic superoxide production via a direct action on the NADPH oxidase. J Clin Invest 1992; 90: 1116–21.
  • Fukahori M, Ichimori H, Nakagawa H, Okino H. Nitric oxide reversibly suppresses xanthine oxidase activity. Free Radical Res Commun 1994; 21: 203–12.
  • Prabhakar SS, Zeballos GA, Zavala MM, Leonard C. Urea inhibits inducible NOS in macrophage cell line. Am J Physiol 1997; 273: C1882-C1888.
  • Bergstrom J, Alvestrand A, Furst P. Plasma and muscle free amino acids in maintenance hemodylasis patients without protein malnutrition. Kidney Int 1990; 38: 108–14.
  • Herbelin A, Nguyen AT, Zingraff J, Urena P, Descampus-Latscha B. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor-α. Kidney Int 1990; 37: 116–25.
  • Bingel M, Lonneman G, Koch KM, Dinarello CA, Shaldon S. Plasma interleukin-1 activity during hemodialysis: the influence of dialysis membrane. Nephron 1988; 50: 273–6.
  • Beasley D, Schwartz JH, Brenner BM. Interleukin-1 induces prolonged L-arginine-dependent cyclic GMP and nitrite production in rat vascular smooth muscle cells. J Clin Invest 1991; 87: 602–8.
  • Townsend Y, Cranston WI. Sites of clearance of leukocytes pyrogen in the rabbit. Clin Sci 1979; 56: 265–8.
  • Urena P, Gogusev J, Valdovinos R, Herblein A, Drueke T. Transcriptional induction of TNF-∝ in uremic patients undergoing hemodialysis. (Abstract). J Am Soc Nephrol 1990; 1: 380.
  • Yokokawa K. Increased nitric oxide production in patients with hypotension during hemodialysis. Ann Intern Med 1995; 123: 35–7.
  • Trznadal K, Pawlicki L, Kendziroa J, Luciak M, Blaszczyk J, Buczynski A. Superoxide anion generation, erythrocyte superoxide dismutase activity, and lipid peroxdation during hemoperfusion and hemodialysis in chronic uremic patients. (Abstract). Free Radical Biol Med 1989; 6: 393–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.